Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share

v3.22.1
Net (Loss) Income Per Share
6 Months Ended
Mar. 31, 2022
Net (Loss) Income Per Share (Abstract)  
Net (Loss) Income Per Share Note 14 – Net (Loss) Income Per Share

Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding for the period. Diluted net (loss) income per share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period after giving effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock appreciation rights and common stock purchase warrants as determined under the treasury stock method.

The following table provides a reconciliation of the net (loss) income per basic and diluted common share outstanding:

Three Months Ended

Six Months Ended

March 31,

March 31,

2022

2021

2022

2021

Net (loss) income

$

(14,177,830)

$

(2,845,981)

$

(20,557,836)

$

14,381,720

Basic weighted average common shares outstanding

80,052,504

75,175,077

80,037,675

72,717,621

Net effect of dilutive instruments:

Stock options

7,147,372

Stock appreciation rights

44,256

Common stock purchase warrants

744,821

Total net effect of dilutive instruments

7,936,449

Diluted weighted average common shares outstanding

80,052,504

75,175,077

80,037,675

80,654,070

Net (loss) income per basic common share outstanding

$

(0.18)

$

(0.04)

$

(0.26)

$

0.20

Net (loss) income per diluted common share outstanding

$

(0.18)

$

(0.04)

$

(0.26)

$

0.18

 

For the six months ended March 31, 2021, approximately 211,000 potentially dilutive instruments were excluded from the computation of net income per diluted weighted average common share outstanding because their effect would have been antidilutive. Due to our net loss for the three and six months ended March 31, 2022 and three months ended March 31, 2021, all potentially dilutive instruments were excluded because their inclusion would have been anti-dilutive. See Notes 9 and 10 for a discussion of our potentially dilutive instruments.